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Endoscopic retrograde cholangiopancreatography (ERCP) is the ﬁrst-choice treatment for patients with obstructive jaundice. However, there are patients
in whom bile duct access is not possible. In these patients, percutaneous transhepatic biliary drainage (PTBD) may be performed as an alternative biliary
drainage method. PTBD is reportedly associated with a moderate mortality rate. In recent years, endoscopic ultrasonography-guided biliary drainage
(EUS-BD) in patients with failed ERCP has been reported as an alternative to PTBD. EUS-BD is classiﬁed into three techniques: (1) EUS-guided chol-
edocoduodenostomy (EUS-CDS); (2) EUS-guided hepatogastrostomy (EUS-HGS); and (3) EUS-guided antegrade (EUS-AG) approach. Herein, we focus on
the current status of EUS-BD in light of these techniques.
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Stent placement under endoscopic retrograde cholangio-
pancreatography (ERCP) is an established procedure for patients
with biliary obstruction. The technical success rate of ERCP was
reported to be over 90%.1 On the other hand, there are patients in
whom bile duct access is not possible because of failed biliary
cannulation or an inaccessible papilla. In these cases, percutaneous
transhepatic biliary drainage (PTBD) is an alternative biliary
drainage method. However, PTBD has an associated mortality rate
of 0%–5.6%.2,3
In recent years, endoscopic ultrasonography-guided biliary
drainage (EUS-BD) in patients with failed ERCP has been reported
to be an alternative method to PTBD or surgical interventions. The
ﬁrst report of EUS-BD was made by Giovannini et al4 in 2001.
Many endoscopists have described EUS-BD, and following their
reports, EUS-BD is presently classiﬁed into 3 techniques as fol-
lows: (1) EUS-guided choledocoduodenostomy (EUS-CDS); (2)
EUS-guided hepatogastrostomy (EUS-HGS); and (3) EUS-guided
antegrade (EUS-AG) approach. However, there are no criteria
regarding which procedure should be selected from these 3
different techniques, and the selection is usually entrusted to each
institution. Herein, we review the status of EUS-BD in light of
these 3 different techniques.Department of Gastroenterology and Hepatology, Tokyo Medical University, Shinjuku-ku, To
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Technical success rate refers to the success rate of the procedure.
Clinical success rate indicates the improvement rate of the symp-
toms or laboratory data after the procedure.
(1) EUS-guided choledocoduodenostomy (EUS-CDS)
Actual technique for EUS-CDS
When a curved linear array endoscope is used for EUS-CDS,
the extrahepatic bile duct is visualized in a long or short posi-
tion. On the other hand, when a forward-view echoendoscope is
used on EUS-CDS, the extrahepatic bile duct is visualized in a
long position, because the visualization of the extrahepatic bile
duct in the short position is difﬁcult for anatomical reasons. After
careful observation of the extrahepatic biliary duct and the
absence of interposing vessels using color Doppler, the extrahe-
patic bile duct is punctured with a 22 G or 19 G FNA needle
(Sono-tip Pro Control, Medi-Globe, Rosenheim, Germany). After
the stylet is removed, bile juice is aspirated and the contrast
medium is injected into the bile duct for cholangiography
(Fig. 1A). Then, a 0.025-inch guidewire (Visiglide, Olympus
medical systems, Tokyo, Japan) is inserted into the outer sheath.
If necessary, a biliary catheter for dilation (Soehendra biliarykyo, Japan
ical University, 6-7-1 Nishishinjuku, Shinjuku, Tokyo 160-0023, Japan.
vier. Open access under CC BY-NC-ND license.
Fig. 1. Cholangiogram ﬁndings of EUS-guided choledocoduodenostomy. (A) Puncture is performed to the extrahepatic bile duct with 19 G needle from the duodenal bulb, and the
contrast medium is injected into the bile duct. (B) A fully covered metal stent is placed through the choledocoduodenostomy ﬁstula.
Gastrointestinal Intervention 2015 4(1), 31–3932dilator, Cook Endoscopy, Germany), an electrocautery dilator
(Cyst-gastro-sets, ENDO-FLEX, Voerde, Germany), a 4-mm
papillary balloon dilator (Hurricane RX, Boston scientiﬁc, MA,
USA), or a combination of these materials, is used for dilation of
the ﬁstula. Finally, a 5-Fr to 10-Fr biliary plastic stent or an 8-mm
to 10-mm covered metal stent (CMS) is placed into the extra-
hepatic bile duct for choledocoduodenostomy (Fig. 1B).Review of published data for EUS-CDS (Table 1)
Technical and clinical success rate
Total 348 cases from 41 papers regarding EUS-CDS have been
reviewed.4–44 The average technical success rate for EUS-CDS was
91.8% (312/340). The reasons for the technical failure of EUS-CDS
were stent impaction,9,32 failure of ﬁstula dilation,23 and guide-
wire dislodgement.5 Thirty four papers described the clinical suc-
cess rates of EUS-CDS. The average clinical success rate was 94.5%
(223/236). There were no signiﬁcant differences in success rate
between the plastic stents and the metal stents [94.1% (64/68) vs.
98.2% (115/117), P ¼ 0.27].
Adverse events
Thirty-eight papers described complications related to EUS-
CDS. The average complication rate related to EUS-CDS was
14.8% (48/324). The most common complication associated with
EUS-CDS was peritonitis 4.0% (11/258). The other complications
were pneumoperitonitis 3.1% (8/258), bleeding 2.7% (7/258), bile
leak 1.9% (5/258), perforation 1.2% (3/258), abdominal pain 1.2%
(3/258), biloma 0.8% (2/258), cholangitis 0.8% (2/258), pancrea-
titis 0.4% (1/258), hemobilia 0.4% (1/258), and stent misplace-
ment 0.4% (1/258). There were no signiﬁcant differences in
complication rate between the plastic stents and the metal stents
[16.4% (17/104) vs. 11.0% (17/154), P ¼ 0.22]. However, these data
have limitations because dedicated stents such as a partially
covered metal stent (PCMS) with an anti-migrating ﬂap38 and a
lumen-apposing metal stent40,43 were included in the metal
stent group.
There were 26 papers that described the details of late com-
plications except stent occlusion. The average late complicationrates after EUS-CDS was 7.3% (13/177), and the causes of all the
complications were stent migration. Plastic stents accounted for
4.2% (4/72) and metal stents 7.6% (6/79). There was no signiﬁcant
difference in the late complications rates between plastic stents and
metal stents (P ¼ 0.59). Moreover, there was no reported mortality
related to EUS-CDS.(2) EUS-guided hepaticogastrostomy (EUS-HGS)
Actual technique for EUS-HGS
By using a curved linear array echoendoscope in a short
position, the intrahepatic bile duct is visualized through the
stomach. EUS-HGS has some differences in terms of points of
the puncture route and placement of a guidewire compared
with EUS-CDS. EUS-HGS has to puncture and penetrate the liver
parenchyma. After puncturing the left intrahepatic bile duct
(segment 2 or 3) using a 22 G or a 19 G FNA needle, a guidewire
is placed in the right intrahepatic bile duct, common bile duct,
or duodenum via the stricture and papilla antegradely. The de-
tails of the methods and the use of the devices for the stent
placement followed the EUS-CDS procedure (Fig. 2A). Finally, a
5-Fr to 10-Fr biliary plastic stent or an 8-mm to 10-mm CMS is
placed into the intrahepatic bile duct for hepaticogastrostomy
(Fig. 2B).Review of published data for EUS-HGS (Table 2)
Technical and clinical success rate
Total 153 cases from 21 papers regarding EUS-HGS have been
reviewed.5,14,19,21,24,26,31,35,37,38,41,42,45–53 The average technical
success rate, for EUS-HGS was 95.4% (146/153). The reasons for the
technical failure of EUS-HGSwere no visualization of suitable target
ducts,21 inability to place the guidewire into the intrahepatic
duct,31,48 slipping out of the guidewire during the ﬁstula dilation,54
and stent misplacement.37
Sixteen papers described the clinical success rate of EUS-HGS.
The average clinical success rate was 90.9% (100/110). There were
Table 1 Overview of the literature on EUS-guided choledochoduodenostomy.
Study n Access
method
Dilation method Stent Overall
technical
success (%)
Overall
clinical
success (%)
Technical
success
by PS (%)
Technical
success
by MS (%)
Early
complication
(%)
Early
complication
by PS (%)
Early
complication
by MS (%)
Details of early
complication
Giovannini4 1 NK BD PS 100 (1/1) 100 (1/1) 100 (1/1) d 0 (0/1) 0 (0/1) d d
Burmester5 2 Fistulotome None PS 50 (1/2) 100 (1/1) 100 (1/1) d 0 (0/2) 0 (0/1) d d
Puspok6 5 NK None PS 100 (5/5) 80 (4/5) 80 (4/5) d 0 (0/4) 0 (0/4) d d
Yamao7 2 KN BD PS 100 (2/2) 100 (2/2) 100 (2/2) d 0 (0/2) 0 (0/2) d d
Fujita8 1 19G BD PS 100 (1/1) 100 (1/1) 100 (1/1) d 0 (0/1) 0 (0/1) d d
Ang9 2 19G NK, BD PS 100 (2/2) 100 (2/2) 2 d 50 (1/2) 50 (1/2) d Pneumoperitoneum
Tarantino10 4 19G, 22G NK, balloon PS 100 (4/4) N.A N.A d N.A N.A d N.A
Yamao11 5 NK BD PS 100 (5/5) 100 (5/5) 100 (5/5) d 20 (1/5) 20 (1/5) d Pneumoperitoneum
Itoi12 4 19G, NK BD PS 75 (3/4) 100 (3/3) 100 (3/3) d 25 (1/4)* 33 (1/3) d Bile peritonitis with
bleeding without blood
transfusion
Brauer13 3 19G, 22G NK PS 67 (2/3) 100 (2/2) 100 (2/2) d 33 (1/3)* 50 (1/2) d Pneumoperitoneum
Horaguchi14 8 19G BD, balloon CMS 100 (8/8) 100 (8/8) d 100 (8/8) 13 (1/8) d 13 (1/8) Peritonitis
Hanada15 4 19G BD PS 100 (4/4) 100 (4/4) 100 (4/4) d 0 (0/4) 0 (0/4) d d
Park16 4 19G NK, BD CMS 100 (4/4) 100 (4/4) d 100 (4/4) 0 (0/4) d 0 (0/4) d
Bellerutti17 1 19G Balloon FCMS 100 (1/1) 100 (1/1) d 100 (1/1) 0 (0/1) d 0 (0/1) d
Artifon18 3 19G NK, PCMS, FCMS 100 (3/3) 100 (3/3) d 100 (3/3) 0 (0/3) d 0 (0/3) d
Iwamuro19 5 NK BD PS 100 (5/5) N.A N.A d 20 (1/5) 20 (1/5) d Sever abdominal pain &
fever
Siddiqui20 8 19G NK FCMS 100 (8/8) 100 (8/8) d 100 (8/8) 25 (2/8) d 25 (2/8) Duodenal perforation 1,
abdominal pain 1
Belletrutti21 4 19G Balloon PS, UCMS, FCMS 100 (4/4) 100 (4/4) 100 (2/2) 100 (2/2) 0 (0/4) 0 (0/2) – –
Hara22 18 NK BD PS 94 (17/18) 100 (17/17) 100 (17/17) d 17 (3/18)* 18 (3/17) d Peritonitis 2, hemobilia 1
Komaki23 15 19G, NK BD PS 93 (14/15) 100 (14/14) 100 (14/14) d 13 (2/15)* 14 (2/14) d Peritonitis 2
Ramirez-
Luna24
9 19G NK, BD, balloon PS 89 (8/9) 63 (5/8) 63 (5/8) d 11 (1/9)* 0 (0/5) d Biloma
Park25 26 19G NK, BD PS, FCMS 92 (24/26) 92 (22/24) N.A N.A 19 (5/26) N.A N.A N.A: (bile peritonitis 2,
pneumoperitoneum 1, the
other was unknnown)
Fabbri26 12 19G NK, balloon CMS 75 (9/12) 100 (9/9) d 100 (9/9) 8 (1/12) d 11 (1/9) Pneumoperitoneum
Kawakubo27 2 19G BD, balloon PS 100 (2/2) N.A N.A d 0 (0/2) 0 (0/2) d d
Katanuma28 1 19G NK, BD PS 100 (1/1) 100 (1/1) 1 d 0 (0/1) 0 (0/1) d d
Attasaranya29 9 19G, NK BD, balloon PS, PCMS 67 (6/9) 100 (6/6) N.A N.A 44 (4/9) N.A N.A N.A
Artifon30 13 19G NK, BD PCMS 100 (13/13) 100 (13/13) d 100 (13/13) 15 (2/13) d 15 (2/13) Bleeding 1, bile leak 1
Kim31 9 19G NK, BD FCMS 100 (9/9) 100 (9/9) d 100 (9/9) 11 (1/9) d 11 (1/9) Pneumoperitoneum with
peritonitis 1
Song32 15 19G NK, BD FCMS 87 (13/15) 100 (13/13) d 100 (13/13) 23 (3/15) d 23 (3/15) Pneumoperitoneum 2,
cholangitis 1
Vila33 26 N.A N.A N.A 86 (19/26) N.A N.A N.A 15 (4/26) N.A N.A N.A
Horaguchi34 5 19G BD, balloon, NK FCMS 100 (5/5) 100 (5/5) d 100 (5/5) 0 (0/5) d 0 (0/5) d
Tonozuka35 4 19G BD, balloon, DS FCMS 100 (4/4) 100 (4/4) d 100 (4/4) 0 (0/4) d 0 (0/4) d
Hara37 18 22G, NK, BD FCMS, PCMS 94 (17/18) 94 (16/17) d N.A 11 (2/18) d 11 (2/18) Peritonitis 2
Kawakubo36 44 19G, NK BD, balloon, SR, DS PS, CMS 95 (42/44) N.A N.A N.A 14 (6/44) 19 (6/31) 0 (0/11) bleeding 1 (PS:MS 1:0),
pneumoperitoneum1
(PS:MS 1:0), perforation
1(PS:MS 1:0).
Song38 17 19G BD, NK PCMS 100 (17/17) 94 (16/17) d 94 (16/17) 12 (2/17) d 12 (2/17) Peritonitis 1, abdominal
pain 1
Miura39 1 19G Cystotome PCMS 100 (1/1) N.A d N.A N.A d N.A N.A
Itoi40 1 19G Cystotome, balloon LAMS 100 (1/1) 100 (1/1) d 100 (1/1) 0 (0/1) d 0 (0/1) d
Hamada41 3 19G Cannula, cystotome,
balloon
zw 100 (3/3) N.A N.A N.A 33 (1/3) 50 (1/2) 0 (0/1) Some
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Gastrointestinal Intervention 2015 4(1), 31–3934no signiﬁcant differences in success rate between the plastic stents
and the metal stents [90.0% vs. 90.6%, P ¼ 0.68].Adverse events
Twenty one papers described complications related to EUS-
HGS. The average complication rate related to EUS-HGS was 17.0%
(26/153). These complications were cholangitis 4.6% (7/153),
bleeding 3.3% (5/153), stent migration 2.6% (4/153), biloma 2.6%
(4/153), bile leakage 2.0% (3/153), pneumoperitonitis 2.0% (3/
153), peritonitis 1.3% (2/153), stent misplacement 1.3% (2/153),
abdominal pain 1.3% (2/153), metal stent shrinkage 0.7% (1/153),
and ileus 0.7% (1/153).
There were no signiﬁcant differences in complication rate be-
tween the plastic stents and the metal stents [22.2% (6/27) vs. 17.3%
(22/127), P ¼ 0.55]. However, these data have limitations because
the dedicated stents such as a PCMS with an anti-migrating ﬂap38
and a dual-ﬂap fully covered metal stent53 were included in the
metal stent group.
There were 16 papers that described the details of the late
complication except stent occlusion. The average late complica-
tion rate after EUS-HGS was 6.1% (6/98), and the causes were
stent migration 5.1% (5/98) and bleeding from a pseudoaneurysm
1.0% (1/98). There was no signiﬁcant difference in the late
complication rates between the plastic stent and the metal stent
(P ¼ 0.62).
Only 1 fatal case related to EUS-HGS was reported. Five days
after performing EUS-HGS, the patient presented again with
abdominal pain and fever. CT scan revealed stent migration with
the proximal end of the stent located within a large biloma. Un-
fortunately, the patient’s clinical status deteriorated because of
sepsis and he died.50(3) EUS-guided antegrade stenting (EUS-AGS)
Actual technique for EUS-AGS
The intrahepatic bile duct or common bile duct is visualized
transgastrically or transduodenally with a curved linear
echoendoscope after using Doppler to avoid any intervening
vessels. The bile duct is punctured by a 22 G or a 19 G FNA
needle. A guidewire is passed into the duodenum through the
stenosis and papilla (Fig. 3A). The details of the methods and the
use of the devices for the stent placement followed the EUS-CDS
procedure. A covered or uncovered metal stent is antegradely
inserted and placed into the stenosis through to the duodenum
via the papilla. Finally, a plastic or metal stent is placed at the
ﬁstula (Fig. 3B).Review of published data on EUS-AGS (Table 3)
Technical and functional success rate
Six papers regarding EUS-AGS have been reviewed.54–58 How-
ever, 2 papers54,58 for EUS-AGS were case reports, and 2 case series
enrolled less than 5 patients.
Total 11 cases from 6 papers regarding EUS-AGS have been
reviewed. The technical success rate for EUS-AGS was 100% (11/11).
There were only 3 papers that described details of the clinical
success rate,6,54,55 which was 100%. However, it is difﬁcult to esti-
mate the efﬁcacy of EUS-AGS because most of the papers were case
reports.
Fig. 2. Cholangiogram ﬁndings of EUS-guided hepaticogastrostomy. (A) Puncture is performed to the intrahepatic bile duct with 19 G needle from the stomach, and the contrast
medium was injected into the bile duct. (B) A plastic stent is placed through the hepaticogastrostomy ﬁstula.
Nobuhito Ikeuchi and Takao Itoi / EUS-guided biliary drainage 35Adverse events
There were only 5 published papers that described complica-
tions associated with EUS-AGS. Only 1 patient had pancreatitis.56Combined transmural biliary stenting on EUS-AGS
Some endoscopists, including ourselves, consider that the
combination of transmural stentingwith EUS-AGSmay prevent bile
leakage from the ﬁstula of the puncture. Park do et al reported the
absence of early complications such as bile leakage in 15 cases
involving the EUS-guided antegrade procedure with HGS including
EUS-AGS and EUS-guided balloon dilation. There is one case of
acute pancreatitis, instead.59 The number of published papers on
EUS-AGS was small, and there was a limitation in terms of whether
combined transmural biliary stenting on EUS-AGS was necessary or
not. Therefore, it will be necessary to accumulate more EUS-AGS
cases for consideration in the future.
Selection of techniques in EUS-BD
There are currently no guidelines for the selection of tech-
niques in EUS-BD. And the number of published papers on EUS-
AGS was small. Some endoscopists may think that EUS-CDS in
light of its potentially lower complication rate relative to EUS-
HGS is a ﬁrst-choice EUS-BD procedure.37,41 However, there was
no signiﬁcant difference in the success rate between EUS-CDS and
EUS-HGS (P ¼ 0.14). In terms of the clinical success rate, there was
no signiﬁcant difference among EUS-CDS, EUS-HGS, and EUS-AGS
(P ¼ 0.36). For the complication rate, there was no signiﬁcant
difference among them [EUS-CDS 14.8% (48/324), EUS-HGS 17.0%
(26/153), and EUS-AGS 12.5% (1/8) (P ¼ 0.81)]. Only one fatal case
was recognized on EUS-HGS.
Japanese multicenter retrospective study, reported that it may
be better to perform EUS-CDS than EUS-HGS because of the
lower complication rate.37 However, there was no signiﬁcant
difference in the complication rates between EUS-CDS and EUS-
HGS (14% vs. 30%, P ¼ 0.70). On the other hand, a prospective
randomized study revealed the efﬁcacy between 24 EUS-CDS and25 EUS-HGS patients. There were no signiﬁcant differences in the
technical success rate, clinical success rate, mean procedure time,
and rate of immediate adverse events between EUS-CDS and
EUS-HGS. Thus, it was concluded that the decision to use one
technique over the other should be at the endoscopist’s
expertise.42Selection of stents in EUS-guided BD
ERCP studies revealed that metal stents had longer patency
periods than plastic stents. On the other hand, there is no deﬁnite
study yet that compared plastic stents with metal stents on EUS-
BD. When a study using plastic stents and metal stents on EUS-
HGS was analyzed, it was shown that the median follow-up
period was 212.9 days (range, 30–610 days), and the follow-up
periods of the plastic stents and metal stents were 164.7 days
(range, 30–267 days) and 325.3 days (range, 120–610 days),
respectively. Moreover, it was shown that the stent patency period
was 176.4 days (range, 30–610 days), and the stent patency pe-
riods of the plastic stents and metal stents were 136.6 days (range,
30–222 days) and 269.3 days (range, 78–610 days), respectively.
On the other hand, Hara et al favored EUS-HGS with plastic stent
instead of a metal stent, because a metal stent could not be
inserted deeply.36
The type of stent to be used should be decided after considering
the bile duct condition, the stent angle, and the perpendicular
orientation of the extrahepatic bile duct, and prognosis of the
patient.PTBD versus EUS-BD
PTBD was ﬁrst reported in 1961 by Catalano et al,60 and this
procedure was the treatment of choice for biliary drainage for
more than 3 decades. It was reported that the technical success
rate of PTBD ranges from 75% to 100%, its clinical success rate
ranges from 65% to 92%, and its complication rate ranges from 9%
to 31%.61–64 The average complication rate of the combined data
for each EUS-guided drainage procedure in our review was not
Table 2 Overview of the literature on EUS-guided hepaticogastrostomy.
Study n Access
method
Dilation
method
Stent Overall
technical
success (%)
Overall
clinical
success (%)
Technical
success by
PS (%)
Technical
success by
MS (%)
Early
complication
(%)
Early
complication
by PS (%)
Early
complication
by MS (%)
Details of early
complication
Burmester5 1 Fistulotome None PS 100 (1/1) 100 (1/1) 100 (1/1) d 0 (0/1) 0 (0/1) d d
Giovannini45 1 19G NK PS 100 (1/1) 100 (1/1) 100 (1/1) d 0 (0/1) 0 (0/1) d d
Arifon46 1 19G None CMS 100 (1/1) 100 (1/1) d 100 (1/1) 0 (0/1) d 0 (0/1) d
Kahaleh47 2 19G, 22G N.A PS 100 (2/2) 100 (2/2) 100 (2/2) d 0 (0/2) 0 (0/2) d d
Bories48 11 19G, 22G Cystotome PS, CMS 91 (10/11) 100 (10/10) 100 (7/7) 100 (3/3) 36 (4/11) 28.6 (2/7) 66.7 (2/3) Metallic stent shrinkage 2
(M2), early clogging 1(P1),
ileus 1 (P1)
Will49 4 19G BD, balloon CMS 100 (4/4) 75 (3/4) d 75 (3/4) 50 (2/4) d 50 (2/4) Slight pain 1, cholangitis
with sl, pain 1
Horaguchi14 5 19G BD, balloon PS 100 (5/5) 80 (4/5) 80 (4/5) d 0 (0/5) 0 (0/5) d d
Martins50 1 19G NK PCMS 100 (1/1) 0 d N.A 100 (1/1) d 100 (1/1) Stent miglation with
biloma 1
Iwamuro19 2 NK BD PS 100 (2/2) 100 (2/2) 100 (2/2) d 50 (1/2) 50 (1/2) d Bile leak and
pneumopenitoneum 1
Park51 5 19G BD, NK FCMS 100 (5/5) 100 (5/5) d 100 (5/5) 0 (0/5) d 0 (0/5) d
Belletrutti21 3 19G Balloon PS 67 (2/3) 50 (1/2) 50 (1/2) d 0 (0/3) 0 (0/3) d d
Ramirez-Luna24 2 19G NK, BD PS 100 (2/2) 100 (2/2) 100 (2/2) d 50 (1/2) 50 (1/2) d Stent miglation 1
Fabbri26 1 19G NK, balloon PCMS 0 d d d 0 (0/1) d 0 (0/1) d
Kim31 4 19G NK, BD FCMS 75 (3/4) 67 (2/3) d 67 (2/3) 25 (1/4) d 25 (1/4) Stent miglation with
peritonitis 1
Tonozuka35 3 19G BD, balloon FCMS 100 (3/3) N.A d N.A 0 (0/3) d 0 (0/3) d
Kawakubo37 20 19G BD, balloon,
NK
PS, CMS 95 (19/20) N.A N.A N.A 30 (6/20) 25 (1/4) 33 (5/15) Bile leak 2 (M1,P1), stent
misplacement 2 (M2),
hemorrhage 1 (M1)
cholangitis 1 (M1),
biloma 1 (M1)
Ogura52 20 19G Catheter FCMS, EBMS 100 (20/20) 100 (20/20) d 100 (20/20) 10 (2/20) d 10 (2/20) Stent miglation 1,
peritonitis 1
Song38 10 19G BD, NK PCMS 100 (10/10) 100 (10/10) d 100 (10/10) 33 (3/10) d 33 (3/10) Pneumoperitonitis 2, minor
bleeding 1
Hamada41 4 19G Cannula,
cystotome,
balloon
CMS 100 (4/4) N.A d N.A 0 (0/4) d 0 (0/4) d
Artifon42 25 19G NK, BD PCMS 96 (24/25) 91 (22/25) d 91 (22/25) 20 (5/25) d 20 (5/25) Bacteremia 1, biloma 2,
bleeding 3
Paik53 28 19G Balloon,
cannula, NK
DFFCMS 96 (27/28) 89 (24/28) d 89 (24/28) 0 (0/28) d 0 (0/28) d
Total 153 95.4 (146/153) 90.9 (100/110) 90.0 (18/20) 90.6 (81/90) 17.0 (26/153) 2.2 (6/27) 17.3 (22/127) d
PS, plastic stent; MS, metal stent; BD, biliary dilator; NK, kneedle knife; CMS, covered metal stent; FCM, fully covered metal stent; PCMS, partial covered metal stent; DFFCMS, double ﬂaps fully covered metal stent; N.A, not
available.
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Fig. 3. Cholangiogram ﬁndings of EUS-guided antegrade stenting. (A) After puncture is performed to the intrahepatic bile duct with 19 G needle from the stomach, dilation is
performed with electorocautery dilator and the guidwire is placed into the duodenum via the stenosis and papilla. (B) An arrow shows an antegradely inserted uncovered metal
stent which is placed into the duodenum via papilla. Also, there is a plastic stent which is placed into the bile duct via the ﬁstula from the stomach.
Nobuhito Ikeuchi and Takao Itoi / EUS-guided biliary drainage 37higher than that of the papers for PTBD in the past 2 decades. In
recent years, many papers have reported on EUS-guided drainage
as an alternative procedure to PTBD. A retrospective study
comparing 26 PTBD and 25 EUS-guided BD patients, including
EUS-CDS, EUS-HGS, and EUS-AGS, reported that the successful
initial stent placement rate and non-complication rate were sta-
tistically signiﬁcant in favor of EUS-BD.65 However, there were
several limitations to this study. In this paper, the reason for the
lower success rate for the initial stent placement was considered
to be the lack of adequate opportunity for PTBD in 50 cases per 7
years in this institution. On the other hand, a prospective and
randomized study evaluated and compared the success and efﬁ-
cacy of PTBD in 12 patients with EUS-CDS in 13 patients with
unresectable malignant biliary obstruction. There were no signif-
icant differences in the technical success rates and mean bilirubin
values in the pre- and post-procedures (30 days). Moreover, the
key advantage of EUS-CDS over PTBD was that EUS-CDS could be
performed during the same session with the failed ERCP.30
Although EUS-BD may become an alternative to PTBD, prospec-
tive large clinical trials of EUS-BD versus PTBD may be required in
the future.
Limitations of EUS-BD
First, a gap is formed between the puncture site of the
duodenal wall and the intrahepatic or extrahepatic bile duct
during the exchange of devices, and this phenomenon may
interfere with stent insertion into the bile duct. Second, the
intrahepatic or extrahepatic bile duct exists in the portal vein at a
close portion. Thus, puncture of the extrahepatic bile duct has a
risk, particularly in patients with a mild dilation of the extrahe-
patic bile duct. Third, the diameter of the working channel of the
echoendoscope is narrow. Therefore, available stents are limited
for EUS-BD. Fourth, EUS-BD is difﬁcult to perform in patients with
no dilated intrahepatic or extrahepatic bile duct. Fifth, patients
who have a hilar bile duct stricture of Bismuth type IV are difﬁcult
to drain by only EUS-BD.Speciﬁc limitations of EUS-CDS
Most patients who have strictures at the distal side of the
extrahepatic bile duct had EUS-CDS. However, when the stricture at
the distal side of the extrahepatic bile duct is close to the hilar
portion of the bile duct, EUS-CDS may be unsuitable. Also, when
patients have a stricture at the duodenal bulb, EUS-CDS should be
avoided.
Speciﬁc limitations of EUS-HGS and EUS-AGS
Puncture and passage of devices such as stents into the ﬁstula on
EUS-HGS may occasionally be difﬁcult in cases of severe ﬁbrosis of
the liver such as in liver cirrhosis, and ﬁbrosis of the intrahepatic
bile duct such as in chronic cholangitis, particularly primary scle-
rosing cholangitis. A hilar bile duct stricture poses difﬁculty in
performing EUS-HGS and EUS-AGS. However, it may be possible to
perform EUS-HGS and EUS-AGS in cases of a hilar bile duct stricture
of Bismuth type I or II. EUS-AGS has to pass over the stricture. Thus,
when advancing devices such as stents into the bile duct stenosis is
difﬁcult on EUS-AGS, the treatment plan should be changed from
EUS-AGS to EUS-HGS, which can be performed without
interruption.
Conclusion
Although prospective large clinical trials of EUS-BD versus
PTBD may be required in the future, EUS-BD may become an
alternative to PTBD for patients with failed ERCP. However, EUS-
BD requires high levels of experience and technique. Further-
more, these procedures should be performed in institutions with
back-up procedure systems such as PTBD or surgery for unsuc-
cessful EUS-BD.
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